Echocardiography and Cardio-Oncology
Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiov...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Negishi, Tomoko [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape - Eggertsen, L. ELSEVIER, 2017, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:28 ; year:2019 ; number:9 ; pages:1331-1338 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.hlc.2019.04.023 |
|---|
| Katalog-ID: |
ELV047422645 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047422645 | ||
| 003 | DE-627 | ||
| 005 | 20230626015638.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.hlc.2019.04.023 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000698.pica |
| 035 | |a (DE-627)ELV047422645 | ||
| 035 | |a (ELSEVIER)S1443-9506(19)30582-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 550 |q VZ |
| 084 | |a 38.48 |2 bkl | ||
| 084 | |a 38.90 |2 bkl | ||
| 084 | |a 42.94 |2 bkl | ||
| 100 | 1 | |a Negishi, Tomoko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Echocardiography and Cardio-Oncology |
| 264 | 1 | |c 2019transfer abstract | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. | ||
| 520 | |a Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. | ||
| 650 | 7 | |a Anthracycline |2 Elsevier | |
| 650 | 7 | |a Myocardial strain |2 Elsevier | |
| 650 | 7 | |a Cancer therapy-related cardiac dysfunction |2 Elsevier | |
| 650 | 7 | |a Cardiotoxicity |2 Elsevier | |
| 650 | 7 | |a Trastuzumab |2 Elsevier | |
| 650 | 7 | |a Ejection fraction |2 Elsevier | |
| 700 | 1 | |a Miyazaki, Sakiko |4 oth | |
| 700 | 1 | |a Negishi, Kazuaki |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Eggertsen, L. ELSEVIER |t Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |d 2017 |g Amsterdam [u.a.] |w (DE-627)ELV000398209 |
| 773 | 1 | 8 | |g volume:28 |g year:2019 |g number:9 |g pages:1331-1338 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.hlc.2019.04.023 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 38.48 |j Marine Geologie |q VZ |
| 936 | b | k | |a 38.90 |j Ozeanologie |j Ozeanographie |q VZ |
| 936 | b | k | |a 42.94 |j Meeresbiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 28 |j 2019 |e 9 |h 1331-1338 |g 8 | ||
| author_variant |
t n tn |
|---|---|
| matchkey_str |
negishitomokomiyazakisakikonegishikazuak:2019----:coadorpyncri |
| hierarchy_sort_str |
2019transfer abstract |
| bklnumber |
38.48 38.90 42.94 |
| publishDate |
2019 |
| allfields |
10.1016/j.hlc.2019.04.023 doi GBV00000000000698.pica (DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 DE-627 ger DE-627 rakwb eng 550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Negishi, Tomoko verfasserin aut Echocardiography and Cardio-Oncology 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier Miyazaki, Sakiko oth Negishi, Kazuaki oth Enthalten in Elsevier Eggertsen, L. ELSEVIER Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape 2017 Amsterdam [u.a.] (DE-627)ELV000398209 volume:28 year:2019 number:9 pages:1331-1338 extent:8 https://doi.org/10.1016/j.hlc.2019.04.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.48 Marine Geologie VZ 38.90 Ozeanologie Ozeanographie VZ 42.94 Meeresbiologie VZ AR 28 2019 9 1331-1338 8 |
| spelling |
10.1016/j.hlc.2019.04.023 doi GBV00000000000698.pica (DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 DE-627 ger DE-627 rakwb eng 550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Negishi, Tomoko verfasserin aut Echocardiography and Cardio-Oncology 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier Miyazaki, Sakiko oth Negishi, Kazuaki oth Enthalten in Elsevier Eggertsen, L. ELSEVIER Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape 2017 Amsterdam [u.a.] (DE-627)ELV000398209 volume:28 year:2019 number:9 pages:1331-1338 extent:8 https://doi.org/10.1016/j.hlc.2019.04.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.48 Marine Geologie VZ 38.90 Ozeanologie Ozeanographie VZ 42.94 Meeresbiologie VZ AR 28 2019 9 1331-1338 8 |
| allfields_unstemmed |
10.1016/j.hlc.2019.04.023 doi GBV00000000000698.pica (DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 DE-627 ger DE-627 rakwb eng 550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Negishi, Tomoko verfasserin aut Echocardiography and Cardio-Oncology 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier Miyazaki, Sakiko oth Negishi, Kazuaki oth Enthalten in Elsevier Eggertsen, L. ELSEVIER Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape 2017 Amsterdam [u.a.] (DE-627)ELV000398209 volume:28 year:2019 number:9 pages:1331-1338 extent:8 https://doi.org/10.1016/j.hlc.2019.04.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.48 Marine Geologie VZ 38.90 Ozeanologie Ozeanographie VZ 42.94 Meeresbiologie VZ AR 28 2019 9 1331-1338 8 |
| allfieldsGer |
10.1016/j.hlc.2019.04.023 doi GBV00000000000698.pica (DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 DE-627 ger DE-627 rakwb eng 550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Negishi, Tomoko verfasserin aut Echocardiography and Cardio-Oncology 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier Miyazaki, Sakiko oth Negishi, Kazuaki oth Enthalten in Elsevier Eggertsen, L. ELSEVIER Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape 2017 Amsterdam [u.a.] (DE-627)ELV000398209 volume:28 year:2019 number:9 pages:1331-1338 extent:8 https://doi.org/10.1016/j.hlc.2019.04.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.48 Marine Geologie VZ 38.90 Ozeanologie Ozeanographie VZ 42.94 Meeresbiologie VZ AR 28 2019 9 1331-1338 8 |
| allfieldsSound |
10.1016/j.hlc.2019.04.023 doi GBV00000000000698.pica (DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 DE-627 ger DE-627 rakwb eng 550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Negishi, Tomoko verfasserin aut Echocardiography and Cardio-Oncology 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier Miyazaki, Sakiko oth Negishi, Kazuaki oth Enthalten in Elsevier Eggertsen, L. ELSEVIER Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape 2017 Amsterdam [u.a.] (DE-627)ELV000398209 volume:28 year:2019 number:9 pages:1331-1338 extent:8 https://doi.org/10.1016/j.hlc.2019.04.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.48 Marine Geologie VZ 38.90 Ozeanologie Ozeanographie VZ 42.94 Meeresbiologie VZ AR 28 2019 9 1331-1338 8 |
| language |
English |
| source |
Enthalten in Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape Amsterdam [u.a.] volume:28 year:2019 number:9 pages:1331-1338 extent:8 |
| sourceStr |
Enthalten in Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape Amsterdam [u.a.] volume:28 year:2019 number:9 pages:1331-1338 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Marine Geologie Ozeanologie Ozeanographie Meeresbiologie |
| institution |
findex.gbv.de |
| topic_facet |
Anthracycline Myocardial strain Cancer therapy-related cardiac dysfunction Cardiotoxicity Trastuzumab Ejection fraction |
| dewey-raw |
550 |
| isfreeaccess_bool |
false |
| container_title |
Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |
| authorswithroles_txt_mv |
Negishi, Tomoko @@aut@@ Miyazaki, Sakiko @@oth@@ Negishi, Kazuaki @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000398209 |
| dewey-sort |
3550 |
| id |
ELV047422645 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047422645</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626015638.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.hlc.2019.04.023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000698.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047422645</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1443-9506(19)30582-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.94</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Negishi, Tomoko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Echocardiography and Cardio-Oncology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anthracycline</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Myocardial strain</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer therapy-related cardiac dysfunction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiotoxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trastuzumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ejection fraction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miyazaki, Sakiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Negishi, Kazuaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Eggertsen, L. ELSEVIER</subfield><subfield code="t">Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape</subfield><subfield code="d">2017</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000398209</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:28</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1331-1338</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.hlc.2019.04.023</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.48</subfield><subfield code="j">Marine Geologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.90</subfield><subfield code="j">Ozeanologie</subfield><subfield code="j">Ozeanographie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.94</subfield><subfield code="j">Meeresbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">28</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">1331-1338</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Negishi, Tomoko |
| spellingShingle |
Negishi, Tomoko ddc 550 bkl 38.48 bkl 38.90 bkl 42.94 Elsevier Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Echocardiography and Cardio-Oncology |
| authorStr |
Negishi, Tomoko |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000398209 |
| format |
electronic Article |
| dewey-ones |
550 - Earth sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
550 VZ 38.48 bkl 38.90 bkl 42.94 bkl Echocardiography and Cardio-Oncology Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction Elsevier |
| topic |
ddc 550 bkl 38.48 bkl 38.90 bkl 42.94 Elsevier Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction |
| topic_unstemmed |
ddc 550 bkl 38.48 bkl 38.90 bkl 42.94 Elsevier Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction |
| topic_browse |
ddc 550 bkl 38.48 bkl 38.90 bkl 42.94 Elsevier Anthracycline Elsevier Myocardial strain Elsevier Cancer therapy-related cardiac dysfunction Elsevier Cardiotoxicity Elsevier Trastuzumab Elsevier Ejection fraction |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s m sm k n kn |
| hierarchy_parent_title |
Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |
| hierarchy_parent_id |
ELV000398209 |
| dewey-tens |
550 - Earth sciences & geology |
| hierarchy_top_title |
Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000398209 |
| title |
Echocardiography and Cardio-Oncology |
| ctrlnum |
(DE-627)ELV047422645 (ELSEVIER)S1443-9506(19)30582-7 |
| title_full |
Echocardiography and Cardio-Oncology |
| author_sort |
Negishi, Tomoko |
| journal |
Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |
| journalStr |
Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
1331 |
| author_browse |
Negishi, Tomoko |
| container_volume |
28 |
| physical |
8 |
| class |
550 VZ 38.48 bkl 38.90 bkl 42.94 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Negishi, Tomoko |
| doi_str_mv |
10.1016/j.hlc.2019.04.023 |
| dewey-full |
550 |
| title_sort |
echocardiography and cardio-oncology |
| title_auth |
Echocardiography and Cardio-Oncology |
| abstract |
Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. |
| abstractGer |
Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. |
| abstract_unstemmed |
Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO |
| container_issue |
9 |
| title_short |
Echocardiography and Cardio-Oncology |
| url |
https://doi.org/10.1016/j.hlc.2019.04.023 |
| remote_bool |
true |
| author2 |
Miyazaki, Sakiko Negishi, Kazuaki |
| author2Str |
Miyazaki, Sakiko Negishi, Kazuaki |
| ppnlink |
ELV000398209 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.hlc.2019.04.023 |
| up_date |
2024-07-06T22:51:01.658Z |
| _version_ |
1803871858625347584 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047422645</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626015638.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.hlc.2019.04.023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000698.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047422645</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1443-9506(19)30582-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.94</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Negishi, Tomoko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Echocardiography and Cardio-Oncology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anthracycline</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Myocardial strain</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer therapy-related cardiac dysfunction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiotoxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trastuzumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ejection fraction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miyazaki, Sakiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Negishi, Kazuaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Eggertsen, L. ELSEVIER</subfield><subfield code="t">Seaweed beds support more juvenile reef fish than seagrass beds in a south-western Atlantic tropical seascape</subfield><subfield code="d">2017</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000398209</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:28</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1331-1338</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.hlc.2019.04.023</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.48</subfield><subfield code="j">Marine Geologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.90</subfield><subfield code="j">Ozeanologie</subfield><subfield code="j">Ozeanographie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.94</subfield><subfield code="j">Meeresbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">28</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">1331-1338</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.400304 |